Loading...
XSHE
002566
Market cap292mUSD
Jul 09, Last price  
5.99CNY
1D
-0.17%
1Q
-24.65%
Jan 2017
-53.20%
IPO
-54.38%
Name

Jilin Jian Yisheng Pharmaceutical Co Ltd

Chart & Performance

D1W1MN
XSHE:002566 chart
P/E
68.36
P/S
3.10
EPS
0.09
Div Yield, %
1.67%
Shrs. gr., 5y
0.01%
Rev. gr., 5y
-6.12%
Revenues
640m
-4.23%
311,753,125414,884,408516,224,102528,925,262600,503,234643,896,712787,894,294819,598,116939,012,6281,034,442,376975,088,2001,012,748,483842,589,906877,929,541877,929,540830,041,323830,041,323853,664,904668,468,925640,173,748
Net income
29m
-44.32%
41,366,69761,128,77087,637,99096,484,10596,626,83487,319,05496,408,83310,911,48613,194,41860,069,57869,079,28576,598,74180,060,09196,020,34996,020,35283,096,99483,096,99994,732,73052,086,05928,999,286
CFO
99m
+67.51%
25,583,75382,661,48120,497,435125,246,25550,725,273079,078,5930000270,654,341167,318,427210,871,994203,514,966215,100,714145,856,177209,130,11558,944,21198,739,613
Dividend
May 22, 20250.1 CNY/sh

Notes

No notes on this company yet
Write a private note on this company, for your eyes only

Profile

Jilin Jian Yisheng Pharmaceutical Co., Ltd. is an enterprise based in Ji'an, China, established in 1997. The company specializes in the production and distribution of a diverse array of goods across the Chinese market. Its offerings include various pharmaceutical products, traditional Chinese herbal medicines, cosmetic items, and food products. Within its medical and health divisions, the firm provides goods in formats such as capsules, injections, tablets, and granules, with a particular emphasis on specialized medicinal products derived from Ginseng, as well as a selection of bee-related products.
IPO date
Mar 18, 2011
Employees
Domiciled in
CN
Incorporated in
CN

Valuation

Title
CNY in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFYFYFY
2025‑122024‑122023‑122023‑002022‑122022‑002021‑122020‑122019‑122018‑122017‑122016‑12
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT